Cargando…
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Insulin-degrading enzyme (IDE) is a ubiquitously expressed zinc-metalloprotease that degrades several pathophysiologically significant extracellular substrates, including insulin and the amyloid β-protein (Aβ), and accumulating evidence suggests that IDE dysfunction may be operative in both type 2 d...
Autores principales: | Zhao, Ji, Li, Lilin, Leissring, Malcolm A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632642/ https://www.ncbi.nlm.nih.gov/pubmed/19144176 http://dx.doi.org/10.1186/1750-1326-4-4 |
Ejemplares similares
-
Insulin-Degrading Enzyme: Paradoxes and Possibilities
por: Leissring, Malcolm A.
Publicado: (2021) -
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
por: Abdul-Hay, Samer O., et al.
Publicado: (2011) -
Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
por: DelleDonne, Anthony, et al.
Publicado: (2009) -
Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway
por: Son, Sung Min, et al.
Publicado: (2015) -
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021)